Analysis of symptomatic course and prognosis and treatment of hypertrophie obstructive cardiomyopathy
Swan DA, Bell B, Oakley CM. Analysis of symptomatic course and prognosis and treatment of hypertrophie obstructive cardiomyopathy. Br Heart J 1971; 33: 671-85.
Hypertrophie cardiomyopathy and pregnancy: Report of a maternal mortality and review of the literature
Shah DM, Sunderji SG. Hypertrophie cardiomyopathy and pregnancy: report of a maternal mortality and review of the literature. Obstet Gynecol Surv 1985; 40: 444-8.
Prognostic relevance of left ventricular function of hypertrophie cardiomyopathy
Romeo F, Ciavolella M, Pelliccia F et al. Prognostic relevance of left ventricular function of hypertrophie cardiomyopathy. Circulation 1987; 76: IV-518 (abstr).
Hypertrophie cardiomyopathy: Is a left ventricular outflow tract gradient a major prognostic determinant?
Romeo F, Pelliccia F, Cristofani R, Martuscelli E, Reale A. Hypertrophie cardiomyopathy: is a left ventricular outflow tract gradient a major prognostic determinant? Eur Heart J 1990; 11: 233-40.
Arrhythmia and prognosis in infants, children and adolescents with hypertrophie cardiomyopathy
McKenna WJ, Franklin RCG, Nihoyannopoulos P et al. Arrhythmia and prognosis in infants, children and adolescents with hypertrophie cardiomyopathy. J Am Coll Cardiol 1988; 11: 147-53.
Verapamil: Its potential for causing serious complications in patients with hypertrophie cardiomyopathy
Epstein SE, Rosing DR. Verapamil: Its potential for causing serious complications in patients with hypertrophie cardiomyopathy. Circulation 1981; 64: 437-41.